Apolipoprotein B/Apolipoprotein A ratio: a novel prognostic factor for pancreatic cancer
Authors:
Preprint
- 26 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective: The relationship between serum lipids and prognosis of pancreatic cancer has not been confirmed. Our purpose in the study was to investigate the associations between serum lipids level and prognosis in patients with pancreatic cancer. Methods: A retrospective study was performed on 286 pancreatic cancer patients who admitted to our hospital from January 1, 2017 to December 31, 2021. Serum lipids level were recorded. Clinical-pathological characteristics, oncologic outcomes, progression free survival (PFS) and overall survival (OS) were collected. The prognostic significance was determined by Kaplan-Meier analysis and Cox proportional hazards regression model. Results: Regarding serum lipids level, compared to normal apolipoprotein B/ apolipoprotein A (ApoB/ApoA), high ApoB/ApoA level indicated a shorter OS (HR:2.028, 95% CI: 1.174-2.504, P = 0.011) and a shorter PFS (HR:1.800, 95% CI: 1.076-3.009, P = 0.025). Other serum lipid molecules were not associated with PFS and OS. Conclusion: ApoB/ApoA might be an independent prognostic factor of pancreatic cancer.Keywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Spotlight on B cellsNature Reviews Cancer, 2016
- Association of cholesterol with risk of pancreatic cancer: A meta-analysisWorld Journal of Gastroenterology, 2015
- Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancerWorld Journal of Gastroenterology, 2014
- A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in MiceGastroenterology, 2013
- Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipidsProceedings of the National Academy of Sciences, 2013
- Metabolic Syndrome Components and Risk Factors for Pancreatic Adenocarcinoma: A Case-Control Study in ChinaDigestion, 2012
- Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysisMetabolism, 2011
- MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of DiseaseCancer Prevention Research, 2009
- Statins Are Not Associated With a Reduced Risk of Pancreatic Cancer at the Population Level, When Taken at Low Doses for Managing Hypercholesterolemia: Evidence From a Meta-Analysis of 12 StudiesAmerican Journal of Gastroenterology, 2008
- Increased lipogenesis in cancer cells: new players, novel targetsCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006